Haloperidol for the treatment of nausea and vomiting in palliative care patients

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Perkins, Paul ^a   Dorman, Saskie ^b  

^a Sue Ryder Care Leckhampton Court Hospice ^*  (United Kingdom)

^b POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL;

CINAHL; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG EFFICACY; EMBASE; HEART ARRHYTHMIA; HUMAN; INFORMATION RETRIEVAL; MEDLINE; METHODOLOGY; MOTOR DYSFUNCTION; NAUSEA; NAUSEA AND VOMITING; NEUROLEPTIC MALIGNANT SYNDROME; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEDATION; SIDE EFFECT; SYSTEMATIC REVIEW; VOMITING;

EID: 70349130022     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006271.pub2     Document Type: Review

References (45)

1. Bregni M, Siena S, Di Nicola M, Bonadonna G, Gianni AM. Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy. European Journal of Cancer 1991;27(5):561-565
2. Buttner M, Walder B, von Elm E, Tramer MR. Is low-dose haloperidol a useful antiemetic? A meta-analysis of published and unpublished randomized trials. Anaesthesiology 2004;101:1454-1463 (Pubitemid 39565004)
3. Cerchietti L, Navigante A, Sauri A, Palazzo F. Hypodermoclysis for control of dehydration in terminal-stage cancer. International Journal of Palliative Nursing 2000;6(8):370-374
4. Christman RS, Weinstein RA, Larose JB. Low-dose haloperidol as antiemetic treatment in gastrointestinal disorders: a double-blind study. Current Therapeutic Research 1974;16(11):1171-1175
5. Christo PJ. Opioid effectiveness and side effects in chronic pain. Anesthesiology Clinics of North America 2003;21:699-713. (Pubitemid 38031688)
6. Cole DR, Duffy DF. Haloperidol for radiation sickness. New York State Journal of Medicine 1974;August:1558-1662
7. Cole RM, Robinson F, Harvey L, Trethowan K, Murdoch B. Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer. Journal of Pain and Symptom Management 1994;9:48-50. (Pubitemid 24061826)
8. De Vries PM. A double-blind cross-over clinical valuation of metoclopramide and a combination of haloperidol and isopropamide iodide in gastroenterology. Arzneimittel-Forschung 1969;19:1766-1767
9. Ettinger DS, Bierman PJ, Bradbury B, Comish CC, Ellis G, Ignoffo RJ, et al. Antiemesis: clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network 2007;5:12-33. (Pubitemid 46212274)
10. Findlay M, Simes RJ, Cox K, Carmichael K, Chey T, McNeil E, Raghaven D. A randomised cross-over trial of antiemetic therapy for platinum-based chemotherapy. Improved control with an intensive multiagent regimen. European Journal of Cancer 1993;29A(3):309-315 (Pubitemid 23025729)
11. Glare P, Pereira G, Kristjanson LJ, Stockler M, Tattersall M. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Supportive Care Cancer 2004; 12:432-440 (Pubitemid 38797099)
12. Grunberg SM, Gala KV, Lampenfeld M, Jamin D, Johnson K, Cariffe P, et al. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study. Journal of Clinical Oncology 1984;2(7):782-787 (Pubitemid 14050685)
13. Herndon CM, Jackson IK, Hallin PA. Management of opioid-induced gastrointestinal effects in patients receiving palliative care. Pharmacotherapy 2002;22:240-250 (Pubitemid 34112884)
14. Kohara H, Ueoka H, Takeyama H, Murakami T, Morita T. Sedation for terminally ill patients with cancer with uncontrollable physical distress. Journal of Palliative Medicine 2005;8(1):20-25 (Pubitemid 40144248)
15. Ladabaum U, Hasler WL. Novel approaches to the treatment of nausea and vomiting. Digestive Diseases 1999;17:125-132
16. McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review. The Journal of Pain 2003;4(5):231-256 (Pubitemid 36807905)
17. Mercadante S, Casuccio A, Mangione S. Medical Treatment for Inoperable Malignant Bowel Obstruction: A Qualitative Systematic Review. Journal of Pain and Symptom Management 2007;33(2):217-223 (Pubitemid 46201883)
18. Neidhart JA, Gagen M, Young Dm Wilson HE. Specific antiemetics for specific cancer chemotherapeutic agents: haloperidol versus benzquinamide. Cancer 1981;47:1439-1443 (Pubitemid 11090515)
19. Owens NJ, Schauer AR, Nightingale CH, Golub GR, Martin RS, Williams HM, et al. Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis. Clinical Pharmacy 1984;3:167-170
20. Ripamonti C, Twycross R, Baines M, Bozzetti F, Capri S, De Conno F, et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Supportive Care in Cancer 2001;9:223-233 (Pubitemid 32537280)
21. Robbins EL, Nagel JD. Haloperidol parenterally for treatment of vomiting and nausea from gastrointestinal disorders in a group of geriatric patients: double-blind, placebo-controlled study. Journal of the American Geriatrics Society 1975;23:38-41.
22. Saller R, Hellenbrecht D. The benefit and risk of high dose metoclopramide in comparison to high dose haloperidol or trifluorpromazine in cisplatin-induced emesis. Klinische Wochen-shcrift 1985; 63:428-432 (Pubitemid 15033394)
23. Silvey L, Carpenter JT, Wheeler RH, Lee J, Conolley C. A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nauseas and vomiting in patients receiving chemotherapy for breast cancer. Journal of Clinical Oncology 1988;6(9):1397-1400 (Pubitemid 19089027)
24. Tornetta FJ. Haloperidol as an antiemetic - guest discussion. Anesthesia and Analgesia - Current Researches 1971;50(6):1024-1026
25. Tornetta FJ. Double-blind evaluation of haloperidol for antiemetic activity. Anesthesia and analgesia. Current Researches 1972;51(6): 964-967
26. Weschules DJ. Tolerability of the compound ABHR in hospice patients. Journal of Palliative Medicine 2005;8(6):1135-1143
27. White C, McPherson A, McCann MA, Sadler A, Fyvie J. Prolonged extra-pyramidal side effects after discontinuation of haloperidol as an antiemetic. Palliative Medicine 2006;20:215-216 (Pubitemid 43871340)
28. Barton MD, Libonati M, Cohen PJ. The use of haloperidol for treatment of postoperative nausea and vomiting - a double-blind placebocontrolled trial. Anesthesiology 1975;42(4):508-512
29. Bentley A, Boyd K. Use of clinical pictures in the management of nausea and vomiting. Palliative Medicine 2001;15:247-253
30. Christman RS, Weinstein RA, Larose JB. Low-dose haloperidol as antiemetic treatment in gastrointestinal disorders: a double-blind study. Current Therapeutic Research, Clinical & Experimental, 1974; 16(11):1171-1176
31. Cole DR, Duffy DF. Haloperidol for radiation sickness: Control of associated nausea, vomiting, and anorexia. New York State Journal of Medicine 1974;74(9):1558-1562
32. Critchley P, Plach N, Grantham M, Marshall D, Taniguchi A, Latimer E, Jadad AR. Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative patient: a systematic review. Journal of Pain and Symptom Management 2001;22:631-634 (Pubitemid 32725803)
33. Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliative Medicine 2001;15:287-295 (Pubitemid 32640547)
34. Ewing G, Rogers M, Barclays S, McCabe J, Martin A, Todd C. Recruiting patients into a primary care based study of palliative care: why is it so difficult?. Palliative Medicine 2004;18:452-459 (Pubitemid 39162658)
35. Glare P, Pereira G, Kristjanson L, Stockler M, Tattersall M. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Supportive Care in Cancer 2004; 12:432-440 (Pubitemid 38797099)
36. Hirst A, Sloan R. Benzodiazepines and related drugs for insomnia in palliative care. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD003346]
37. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of randomized clinical trials: is blinding necessary?. Controlled clinical trials 1996;17:1-12. (Pubitemid 26120810)
38. Jordhoy M, Kaasa S, Fayers P, Ovreness T, Underland G, Ahlner-Elmqvist M. Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial. Palliative Medicine 1999;13:299-310. (Pubitemid 29378208)
39. Keeley P. Nausea and vomiting in people with cancer and other chronic diseases. BMJ Clinical Evidence 2007;06:2406.
40. Klinkenberg M, Willems DL, van der Wal G, Deeg DJH. Symptom burden in the last week of life. Journal of Pain and Symptom Management 2004;27:5-13. (Pubitemid 38050243)
41. Mannix KA. Palliation of nausea and vomiting. Oxford Textbook of Palliative Medicine. Oxford University Press, 2004.
42. Reuben DB, Mor V. Nausea and vomiting in terminal cancer patients. Archives of Internal Medicine 1986;146:2021-2023 (Pubitemid 16006696)
43. Robbins EL, Nagel JD. Haloperidol parenterally for treatment of vomiting and nausea from gastrointestinal disorders in a group of geriatric patients: double-blind, placebo-controlled study. Journal of the American Geriatrics Society 1975;23(1):38-41.
44. Susman VL. Clinical management of neuroleptic malignant syndrome. The Psychiatric Quarterly 2001;72:325-336 (Pubitemid 33743589)
45. Twycross R, Back I. Nausea and vomiting in advanced cancer. European Journal of Palliative Care 1998;5:39-45.